About Lippon
Lippon offers products and services including Tablets and Capsules and Injectables.
- SectorsHealthcare
- Email••••••••
- Legal Name Lippon Pharma Private Limited
- Date of Incorporation 04 Jun, 2019
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹8.82 Cr
FY 2025 · +36% YoY
- Net Profit₹31.8 Lakh
FY 2025 · 4% margin
- EBITDA₹55 Lakh
FY 2025 · 6% margin
Associated legal entities of Lippon
Lippon operates through Lippon Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lippon Pharma Private Limited CIN U51909TN2019PTC129735 | Active | 04 Jun 2019 | Chennai, Tamil Nadu | ₹8.8 Cr | – | 6 | View details |
Products & Services of Lippon
Lippon offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injectables.
Tablets and capsules are manufactured for general medicines and various specialties, including cardiology and neurology.
Injectables are provided for specialized treatments in fields like diabetology and orthopedics.
Board of directors of Lippon Pharma Private Limited (Lippon)
Lippon Pharma Private Limited is the primary company behind Lippon. The board of Lippon Pharma Private Limited currently have 6 directors; the longest-serving is Nazerkhan Alfin, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nazerkhan Alfin DIN 08471798 | Director | 04 Jun 2019 | 7 yrs 4 mo | Lippon Pharma Private Limited |
| Ramanathan Rajeshwari DIN 08471800 | Director | 04 Jun 2019 | 7 yrs 4 mo | Lippon Pharma Private Limited |
| Venkatraman DIN 08450835 | Director | 04 Jun 2019 | 7 yrs 4 mo | Lippon Pharma Private Limited |
| Kaliyaperumal Vadivel DIN 08450844 | Director | 04 Jun 2019 | 7 yrs 4 mo | Lippon Pharma Private Limited |
| Komala DIN 09175842 | Director | 14 May 2021 | 5 yrs 4 mo | Lippon Pharma Private Limited |
| . Ramalingam DIN 10405203 | Director | 27 Nov 2023 | 2 yrs 10 mo | Lippon Pharma Private Limited |
Financials of Lippon
Figures of Lippon Pharma Private Limited, the primary company behind Lippon, for FY 2025. Revenue was ₹8.82 Cr (+36% year on year). Net profit was ₹31.8 Lakh (4% margin). EBITDA was ₹55 Lakh (6% margin). Revenue has grown at a compounded annual rate of +43% over three years and +127% over five years.
- ₹8.82 CrRevenue · FY 2025 · +36% YoY
- ₹31.8 LakhNet profit · 4% margin
- ₹55 LakhEBITDA · 6% margin
- ₹9 LakhPaid-up capital
- +43%Revenue CAGR, 3 years
- +127%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lippon Pharma Private Limited are on its company page.
Detailed financial statements for Lippon
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Lippon
10 companies that operate in the same segment as Lippon (Pharmacy & Healthcare Retail Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | – | – | |
Online community and B2B platform for pharmacy professionals is operated. | 2012 | Singapore, Singapore | USD 10 M | – | – | |
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 | |
Offers a B2B managed marketplace for pharmacies | 2019 | Bengaluru, Karnataka, India | USD 20.02 M | USD 20.23 M | 218 | |
Digital healthcare tools are offered for pharmacies and clinics management. | 2012 | Mumbai, Maharashtra, India | USD 929.11 M | USD 805.55 M | 221 | |
Prescription drugs refill management solutions | 2015 | San Francisco, California, United States | USD 105.54 M | – | 99 | |
On-demand prescription delivery is facilitated for patients through pharmacists' workflows. | 2016 | Jacksonville, United States | USD 30.64 M | – | 95 | |
Medication management systems are supplied to healthcare providers and pharmacies. | 1968 | Columbus, Ohio, United States | USD 8.3 M | – | – | |
Provider of supply chain management platform | 2009 | Columbus, Ohio, United States | USD 5.76 M | – | 55 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lippon
The primary company behind Lippon, Lippon Pharma Private Limited, reported revenue of ₹8.82 Cr for FY 2025, up 36% year on year.
Lippon is recognized as an innovation-led national pharmaceutical company that was established by experienced health care professionals and has maintained a successful presence in the market for several years. High-quality innovative medicines and exclusive formulations are provided by Lippon to meet the needs of hospitals, doctors, and patients, focusing on affordable pricing and various specialties like cardiology and neurology. An efficient distribution network is utilized in South India, supported by dedicated professionals and modern technology for formulation and manufacturing, ensuring global standards and timely supply.
Lippon offers Tablets and Capsules and Injectables.
Lippon operates through Lippon Pharma Private Limited.
The legal entities of Lippon currently have 6 directors, including . Ramalingam, Komala, Nazerkhan Alfin and others.